glycyrrhetinic acid and Shock, Septic

glycyrrhetinic acid has been researched along with Shock, Septic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, Z; Ji, H; Lai, Y; Lai, Z; Long, W; Sha, L; Wu, K; You, R; Yu, X; Zhang, Y	1

Other Studies

1 other study(ies) available for glycyrrhetinic acid and Shock, Septic

Article	Year
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile. Journal of medicinal chemistry, 2013, Mar-14, Volume: 56, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Cell Line; Extracellular Signal-Regulated MAP Kinases; Female; Glycyrrhetinic Acid; I-kappa B Proteins; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Receptors, Glucocorticoid; Shock, Septic; Triterpenes; Tumor Necrosis Factor-alpha	2013

Article

Year

Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.

Journal of medicinal chemistry, 2013, Mar-14, Volume: 56, Issue:5

Topics: Animals; Anti-Inflammatory Agents; Cell Line; Extracellular Signal-Regulated MAP Kinases; Female; Glycyrrhetinic Acid; I-kappa B Proteins; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Receptors, Glucocorticoid; Shock, Septic; Triterpenes; Tumor Necrosis Factor-alpha

2013